Overview: In November 2020 Russia exported $30B and imported $22.1B, resulting in a positive trade balance of $7.92B. Between November 2019 and November 2020 the exports of Russia have decreased by $-6.25B (-17.3%) from $36.2B to $30B, while imports decreased by $-203M (-0.91%) from $22.3B to $22.1B.
Trade: In November 2020, the top exports of Russia were Crude Petroleum ($5.83B), Commodities not elsewhere specified ($4.3B), Refined Petroleum ($3.04B), Gold ($2.18B), and Coal Briquettes ($1.02B). In November 2020 the top imports of Russia were Telephones ($1.17B), Packaged Medicaments ($858M), Vehicle Parts ($772M), Commodities not elsewhere specified ($711M), and Cars ($684M).
Origins: In November 2020 the exports of Russia were mainly from MOSCOW, THE CAPITAL OF RUSSIAN FEDERATION ($12.2B), ST. PETERSBURG ($2.17B), SAKHALIN REGION ($1.04B), KEMEROVO REGION ($934M), and KRASNOYARSK TERRITORY ($902M), while imports destinations were mainly MOSCOW, THE CAPITAL OF RUSSIAN FEDERATION ($9.91B), MOSCOW REGION ($2.43B), ST. PETERSBURG ($2.12B), SVERDLOVSK REGION ($784M), and KALININGRAD REGION ($584M).
Destinations: In November 2020, Russia exported mostly to China ($4.27B), United Kingdom ($2.65B), Netherlands ($2.23B), Germany ($1.81B), and Belarus ($1.6B), and imported mostly from China ($5.16B), Germany ($2.38B), United States ($1.25B), Belarus ($1.13B), and Italy ($1.05B).
Growth: In November 2020, the decrease in Russia's year-by-year exports was explained primarily by an decrease in exports to Netherlands ($-1.02B or -31.4%), China ($-923M or -17.8%), and Italy ($-683M or -49.6%), and product exports decrease in Crude Petroleum ($-4.13B or -41.5%), Refined Petroleum ($-2.4B or -44.1%), and Commodities not elsewhere specified ($-1.1B or -20.3%). In November 2020, the decrease in Russia's year-by-year imports was explained primarily by an decrease in imports from France ($-228M or -25.3%), United Kingdom ($-100M or -24.4%), and Ukraine ($-82.5M or -22.1%), and product imports decrease in Packaged Medicaments ($-805M or -48.4%), Blood, antisera, vaccines, toxins and cultures ($-105M or -25.4%), and Computers ($-61.9M or -8.51%).